Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steffen Lerch"'
Autor:
Frauke Zipp, Christina F. Vogelaar, Robert Nitsch, Yvonne Gärtner, Micaela Domingues, Carine Thalman, Nicholas Hanuscheck, Lynn Bitar, Steffen Lerch, Andrea Schnatz
Publikováno v:
Cellular and Molecular Neurobiology
Neurons of the central nervous system (CNS) that project long axons into the spinal cord have a poor axon regenerative capacity compared to neurons of the peripheral nervous system. The corticospinal tract (CST) is particularly notorious for its poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5342c98f4e0668486589425c82730dd
Autor:
Jérôme Birkenstock, Jonathan Kipnis, Robert Nitsch, Shibajee Mandal, Andrea Schnatz, Cedric S. Raine, Stefan Bittner, Frauke Zipp, Steffen Lerch, Katharina Birkner, Ulrike Bühler, Johannes Vogt, Christina F. Vogelaar
Publikováno v:
Science translational medicine. 10(430)
Ongoing axonal degeneration is thought to underlie disability in chronic neuroinflammation, such as multiple sclerosis (MS), especially during its progressive phase. Upon inflammatory attack, axons undergo pathological swelling, which can be reversib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f265f3c98ff8a34a581f5a8995e15c
https://pubmed.ncbi.nlm.nih.gov/29491183
https://pubmed.ncbi.nlm.nih.gov/29491183
Autor:
Felix Luessi, Valérie Jolivel, Steffen Lerch, Bettina Trinschek, Mario Hubo, Helmut Jonuleit, Laura Poisa-Beiro, Stefan H.P. Kraus, Magdalena Paterka, Frauke Zipp
Publikováno v:
International Immunopharmacology. 18:347-357
Cladribine is a purine nucleoside analog developed to treat lymphoid malignancies. Reported therapeutic benefits for the autoimmune disease multiple sclerosis indicate additional immunomodulatory effects beyond the well-characterized cytotoxic activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791e098f3ef57b49b455e270095ee6fe
https://doi.org/10.1016/j.intimp.2013.11.027
https://doi.org/10.1016/j.intimp.2013.11.027
Autor:
Tobias Bopp, Bettina Trinschek, Valérie Jolivel, Helmut Jonuleit, Frauke Zipp, Stefan H.P. Kraus, Steffen Lerch, Esther Witsch, Heinz Wiendl, Felix Luessi, Magdalena Paterka, Torsten Roberg, Laura Poisa-Beiro, Luisa Klotz, Robert Ploen
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 21(14)
Objective: We aimed to clarify whether fingolimod has direct effects on antigen-presenting cells in multiple sclerosis patients. Methods: Frequency and phenotype of directly ex vivo dendritic cells and monocytes were analyzed in 43 individuals, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f2229f061b77ea35fc8a8e98ef5b73
https://pubmed.ncbi.nlm.nih.gov/25732840
https://pubmed.ncbi.nlm.nih.gov/25732840